Skip to main content
. 2016 Jul 27;90(16):7118–7130. doi: 10.1128/JVI.00603-16

FIG 6.

FIG 6

Inhibition of splenomegaly and lymphadenopathy in LP-BM5-infected mice treated with I-152. Mice were infected as described in Materials and Methods and treated i.p. with I-152 (30 μmol/mouse) 3 days a week for a total of 9 weeks. Values represent the means ± SDs for 5 animals and were obtained at 9 weeks postinfection. *, P < 0.05.